[go: up one dir, main page]

PT88173A - Processo para a preparacao de 1,4-di-hidropiridinas e sua aplicacao como medicamentos - Google Patents

Processo para a preparacao de 1,4-di-hidropiridinas e sua aplicacao como medicamentos

Info

Publication number
PT88173A
PT88173A PT88173A PT8817388A PT88173A PT 88173 A PT88173 A PT 88173A PT 88173 A PT88173 A PT 88173A PT 8817388 A PT8817388 A PT 8817388A PT 88173 A PT88173 A PT 88173A
Authority
PT
Portugal
Prior art keywords
methyl
dihydro
hydropyridines
medicines
preparation
Prior art date
Application number
PT88173A
Other languages
English (en)
Other versions
PT88173B (pt
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of PT88173A publication Critical patent/PT88173A/pt
Publication of PT88173B publication Critical patent/PT88173B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT88173A 1987-08-03 1988-08-02 Processo para a preparacao de 1,4-di-hidropiridinas e sua aplicacao como medicamentos PT88173B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401799A EP0302980B1 (fr) 1987-08-03 1987-08-03 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (2)

Publication Number Publication Date
PT88173A true PT88173A (pt) 1989-06-30
PT88173B PT88173B (pt) 1995-03-01

Family

ID=8198243

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88173A PT88173B (pt) 1987-08-03 1988-08-02 Processo para a preparacao de 1,4-di-hidropiridinas e sua aplicacao como medicamentos

Country Status (34)

Country Link
US (1) US4952592A (pt)
EP (1) EP0302980B1 (pt)
JP (1) JPH0733383B2 (pt)
KR (1) KR960001724B1 (pt)
CN (1) CN1038587C (pt)
AT (1) ATE61588T1 (pt)
BE (1) BE1001055A4 (pt)
CA (2) CA1306261C (pt)
CH (1) CH675999A5 (pt)
CZ (1) CZ282077B6 (pt)
DD (1) DD282008A5 (pt)
DE (2) DE3768658D1 (pt)
DK (1) DK430288A (pt)
ES (1) ES2007543A6 (pt)
FI (1) FI91406C (pt)
GB (1) GB2208861B (pt)
GR (2) GR880100507A (pt)
HU (1) HU204523B (pt)
IE (1) IE60358B1 (pt)
IL (1) IL87321A (pt)
IN (1) IN167550B (pt)
IS (1) IS1549B (pt)
IT (1) IT1235013B (pt)
LU (1) LU87297A1 (pt)
MA (1) MA21344A1 (pt)
NO (1) NO170934C (pt)
NZ (1) NZ225661A (pt)
PH (1) PH25645A (pt)
PT (1) PT88173B (pt)
RU (1) RU2036922C1 (pt)
SK (1) SK541388A3 (pt)
TN (1) TNSN88081A1 (pt)
YU (1) YU46547B (pt)
ZA (1) ZA885684B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
EP0854721B1 (en) * 1995-08-02 2001-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
MX2007000979A (es) * 2004-07-26 2007-07-11 Cotherix Inc Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
ES8507495A1 (es) * 1984-03-27 1985-09-01 Inst Investigacion Desarrollo Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
JPH068294B2 (ja) * 1985-02-26 1994-02-02 富山化学工業株式会社 新規な1,4−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤

Also Published As

Publication number Publication date
MA21344A1 (fr) 1989-04-01
KR960001724B1 (ko) 1996-02-03
DE3825962A1 (de) 1989-02-16
TNSN88081A1 (fr) 1990-07-10
IE882364L (en) 1989-02-03
US4952592A (en) 1990-08-28
HUT54142A (en) 1991-01-28
IS1549B (is) 1994-06-08
DE3768658D1 (de) 1991-04-18
LU87297A1 (fr) 1989-02-02
NO170934B (no) 1992-09-21
SK278775B6 (sk) 1998-02-04
SK541388A3 (en) 1998-02-04
ATE61588T1 (de) 1991-03-15
FI91406C (fi) 1994-06-27
NZ225661A (en) 1990-08-28
IL87321A0 (en) 1989-01-31
HU204523B (en) 1992-01-28
RU2036922C1 (ru) 1995-06-09
IS3378A7 (is) 1989-02-04
CZ541388A3 (en) 1997-01-15
IE60358B1 (en) 1994-06-29
JPH0733383B2 (ja) 1995-04-12
EP0302980B1 (fr) 1991-03-13
NO883406L (no) 1989-02-06
AU2033088A (en) 1989-02-09
CN1031531A (zh) 1989-03-08
DK430288D0 (da) 1988-08-02
PT88173B (pt) 1995-03-01
PH25645A (en) 1991-08-21
FI883603A0 (fi) 1988-08-01
IT1235013B (it) 1992-06-16
FI883603A (fi) 1989-02-04
JPH01294675A (ja) 1989-11-28
FI91406B (fi) 1994-03-15
GR3001984T3 (en) 1992-11-23
CZ282077B6 (cs) 1997-05-14
YU147088A (en) 1990-04-30
KR890003743A (ko) 1989-04-17
CA1306261C (fr) 1992-08-11
IT8848259A0 (it) 1988-08-02
BE1001055A4 (fr) 1989-06-20
CN1038587C (zh) 1998-06-03
AU606441B2 (en) 1991-02-07
CH675999A5 (en) 1990-11-30
YU46547B (sh) 1993-11-16
NO170934C (no) 1992-12-30
ES2007543A6 (es) 1989-06-16
DK430288A (da) 1989-02-03
NO883406D0 (no) 1988-08-01
GR880100507A (el) 1989-05-25
IL87321A (en) 1993-04-04
GB8818356D0 (en) 1988-09-07
IN167550B (pt) 1990-11-10
DD282008A5 (de) 1990-08-29
ZA885684B (en) 1989-04-26
CA1306262C (fr) 1992-08-11
EP0302980A1 (fr) 1989-02-15
GB2208861A (en) 1989-04-19
GB2208861B (en) 1991-07-17

Similar Documents

Publication Publication Date Title
PT88173A (pt) Processo para a preparacao de 1,4-di-hidropiridinas e sua aplicacao como medicamentos
FI875229A0 (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
NO901657L (no) Fuktende baeremiddel for topisk administrering av vitamin a syre.
ATE53376T1 (de) Entzuendungshemmende agentien.
SE9300758L (sv) Förfarande för framställning av kavulansyrasalter
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
FI99013B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
ES541215A0 (es) Un metodo para preparar un cianoimidazol-nucleosido
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
SE8605255D0 (sv) 4h-benzo(4,5)cyclohepta(1,2-b)thiophene derivatives
FI93008B (fi) Menetelmä bakteerien vastaisten 6-fluori-1,4-dihydrokinol-4-oni-3-karboksyylihappojohdannaisten valmistamiseksi
DE3764457D1 (de) Empfaengnisverhuetende, waessrig-saure zusammensetzung und verfahren zu ihrer herstellung.
IT8019354A0 (it) Derivati dell'acido nicotinico adattivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8722079A0 (it) Derivati dell'acido 2-osso-1-azetidin solfonico dotati di attivita' antibatterica, procedimento per la loro preparazione e relative formulazioni farmaceutiche.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940822

PC3A Transfer or assignment

Free format text: 960403 PRODESFARMA S.A. ES

PC3A Transfer or assignment

Free format text: 980202 ALMIRALL-PRODESFARMA, SOCIEDAD ANONIMA ES

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010228